Navigation Links
Voyager RX Coronary Dilatation Catheter 30 mm

ProductsVoyager RX Coronary Dilatation Catheter 30 mm
Company Guidant Corporation
Item Voyager RX Coronary Dilatation Catheter 30 mm
Features 
  • New tapered tip with .017 tip entry profile designed to cross tight lesions
  • Improved tip-to-wire conformability for confident track and cross
  • Polyurethane tip material is flexible yet durable for tough lesions
  • Flexible tungsten marker technology allows catheter to conform to tortuous anatomy
Description Utilizing technology developed over Guidants 20-year history, the VOYAGER RX Dilatation Catheter provides the new foundation for successful treatment outcomes. It combines a new low profile, tapered tip design with a lower profile shaft,more flexible markers, and short taper balloon technology.1 Now you can cross tight and tortuous anatomy with even greater confidence, opening up a world of new treatment options.
Info Guidant Corporation
Customer Service: (317) 971-2000
Web site: http://www.guidant.com/

Related medicine products :

1. Voyager RX Coronary Dilatation Catheter 8 mm
2. Voyager RX Coronary Dilatation Catheter 12 mm
3. Voyager RX Coronary Dilatation Catheter 15 mm
4. Voyager RX Coronary Dilatation Catheter 20 mm
5. Voyager RX Coronary Dilatation Catheter 25 mm
6. Metrologic MS9520 Voyager
7. Voyager Pulse Oximeter
8. Atlantis SR Pro Coronary Imaging Catheter
9. Cypher Sirolimus-eluting Coronary Stent
10. MULTI-LINK OTW PIXEL Coronary Stent System
11. MULTI-LINK RX PIXEL Coronary Stent System
... Extend is a three-part differential control assayed for ... J Series, T Series, AcT/AcT diff/AcT diff2, MD ... 1600, 1700, and 1800; ABX Micros 60; and ... has an open-vial stability of 30 days and ...
... Retics is a 5-part differential control that ... Coulter GENS, STKS, LH 750/LH 755, MAXM ... and manual reticulocyte values for all three ... percentages vary and are within clinically significant ...
... whole blood assayed hematology control, offers complete ... differential available with the Coulter GENS, STKS, ... 14-day open-vial stability, 105-day closed-vial stability and ... levels. The 4.0ml pierceable cap vial is ...
Antelys Peek Lumbar Technologies provides a range of varied heights and angles to correct lumbar lordosis and the associated sagital balance....
Medicine Products:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: